VICAL INC (VICL) Stock Price, Forecast & Analysis
USA - NASDAQ:VICL - US9256021042
VICL Key Statistics, Chart & Performance
The current stock price of VICL is 0.676 null. In the past month the price decreased by -8.65%. In the past year, price decreased by -51.37%.
VICL Latest News, Press Relases and Analysis
About VICL
Company Profile
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs.
Company Info
VICAL INC
10390 PACIFIC CENTER COURT
SAN DIEGO CA 92121
CEO: Vijay B. Samant
Phone: 858-646-1100
VICAL INC / VICL FAQ
What does VICL do?
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs.
What is the current price of VICL stock?
The current stock price of VICL is 0.676 null. The price decreased by -15.68% in the last trading session.
Does VICAL INC pay dividends?
VICL does not pay a dividend.
What is the ChartMill technical and fundamental rating of VICL stock?
VICL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Would investing in VICAL INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on VICL.
Can you provide the ownership details for VICL stock?
You can find the ownership structure of VICAL INC (VICL) on the Ownership tab.
VICL Technical Analysis
VICL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to VICL. The financial health of VICL is average, but there are quite some concerns on its profitability.
VICL Financial Highlights
Over the last trailing twelve months VICL reported a non-GAAP Earnings per Share(EPS) of -0.74. The EPS increased by 30.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -7090.06% | ||
| ROA | -28.39% | ||
| ROE | -29.18% | ||
| Debt/Equity | 0 |